These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8555955)

  • 21. HIV prevalence and risk behaviour among intravenous drug users attending HIV counselling and testing centres in Paris.
    Helal H; Momas I; Prétet S; Marsal L; Poinsard R
    Addiction; 1995 Dec; 90(12):1627-33. PubMed ID: 8555954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discriminating needle exchange attenders from non-attenders.
    Frischer M; Elliott L
    Addiction; 1993 May; 88(5):681-7. PubMed ID: 8518719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Needle and syringe exchange programmes and prevalence of HIV infection among intravenous drug users in China.
    Luo W; Wu Z; Poundstone K; McGoogan JM; Dong W; Pang L; Rou K; Wang C; Cao X
    Addiction; 2015 Jan; 110 Suppl 1():61-7. PubMed ID: 25533865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Needle exchange program attendance and injection risk in Providence, Rhode Island.
    Longshore D; Bluthenthal RN; Stein MD
    AIDS Educ Prev; 2001 Feb; 13(1):78-90. PubMed ID: 11252456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of syringe exchange use on high-risk injection drug users: a cohort study.
    Bluthenthal RN; Kral AH; Gee L; Erringer EA; Edlin BR
    AIDS; 2000 Mar; 14(5):605-11. PubMed ID: 10780722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Needle exchange use among a cohort of injecting drug users.
    Schoenbaum EE; Hartel DM; Gourevitch MN
    AIDS; 1996 Dec; 10(14):1729-34. PubMed ID: 8970694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug consumption rooms in Catalonia: A comprehensive evaluation of social, health and harm reduction benefits.
    Folch C; Lorente N; Majó X; Parés-Badell O; Roca X; Brugal T; Roux P; Carrieri P; Colom J; Casabona J;
    Int J Drug Policy; 2018 Dec; 62():24-29. PubMed ID: 30352331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Injecting drug use in prison: prevalence and implications for needle exchange policy.
    Wright NM; Tompkins CN; Farragher TM
    Int J Prison Health; 2015; 11(1):17-29. PubMed ID: 25751704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An analysis of 15-19-year-old first attenders at the Dublin Needle Exchange, 1990-97.
    Mullen L; Barry J
    Addiction; 2001 Feb; 96(2):251-8. PubMed ID: 11182870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV infection among injecting drug users in Asia: an evolving public health crisis.
    Wodak A; Crofts N; Fisher R
    AIDS Care; 1993; 5(3):313-20. PubMed ID: 8218466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of injecting and injecting risk-taking behaviour among methadone-maintenance clients.
    Darke S; Swift W; Hall W; Ross M
    Addiction; 1994 Mar; 89(3):311-6. PubMed ID: 8173500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measuring effectiveness of needle and syringe exchange programmes for prevention of HIV among injecting drug users.
    Amundsen EJ
    Addiction; 2006 Jul; 101(7):911-2. PubMed ID: 16771880
    [No Abstract]   [Full Text] [Related]  

  • 33. Lower syringe sharing and re-use after syringe legalization in Rhode Island.
    Rich JD; Hogan JW; Wolf F; DeLong A; Zaller ND; Mehrotra M; Reinert S
    Drug Alcohol Depend; 2007 Jul; 89(2-3):292-7. PubMed ID: 17386980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV risk behaviors among women in methadone maintenance treatment.
    Grella CE; Anglin D; Annon JJ
    Subst Use Misuse; 1996 Feb; 31(3):277-301. PubMed ID: 8834263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Buprenorphine misuse among heroin and amphetamine users in Malmo, Sweden: purpose of misuse and route of administration.
    Hakansson A; Medvedeo A; Andersson M; Berglund M
    Eur Addict Res; 2007; 13(4):207-15. PubMed ID: 17851242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and predictors of transitions to and away from syringe exchange use over time in 3 US cities with varied syringe dispensing policies.
    Green TC; Bluthenthal RN; Singer M; Beletsky L; Grau LE; Marshall P; Heimer R
    Drug Alcohol Depend; 2010 Sep; 111(1-2):74-81. PubMed ID: 20537814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: implications for HIV and hepatitis C prevention.
    Morissette C; Cox J; De P; Tremblay C; Roy E; Allard R; Stephenson R; Graves L
    Int J Drug Policy; 2007 May; 18(3):204-12. PubMed ID: 17689367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of a needle social marketing strategy to control HIV among injecting drug users in China.
    Wu Z; Luo W; Sullivan SG; Rou K; Lin P; Liu W; Ming Z
    AIDS; 2007 Dec; 21 Suppl 8():S115-22. PubMed ID: 18172379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gender differences in sharing injecting equipment by drug users in England.
    Bennett GA; Velleman RD; Barter G; Bradbury C
    AIDS Care; 2000 Feb; 12(1):77-87. PubMed ID: 10716020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polydrug Use and Heterogeneity in HIV Risk Among People Who Inject Drugs in Estonia and Russia: A Latent Class Analysis.
    Tavitian-Exley I; Boily MC; Heimer R; Uusküla A; Levina O; Maheu-Giroux M
    AIDS Behav; 2018 Apr; 22(4):1329-1340. PubMed ID: 28699018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.